Valeant (VRX) to Syndicate $500M of Incremental Term Loans
Tweet Send to a FriendGet Alerts VRX Hot Sheet
Up)
Trade VRX Now!
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) announced plans to syndicate $500 million of incremental term loans under its existing senior secured credit facilities to fund repayment of amounts outstanding under its existing $275 million revolving facility and for general corporate purposes, including acquisitions.
The incremental term loans will mature in 2019 and are expected to have terms that are similar to the Company's existing $600 million Term Loan B facility, with certain modifications. The incremental term loans are expected to close in June 2012, subject to market and other customary conditions.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The incremental term loans will mature in 2019 and are expected to have terms that are similar to the Company's existing $600 million Term Loan B facility, with certain modifications. The incremental term loans are expected to close in June 2012, subject to market and other customary conditions.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Valeant Pharmaceuticals Announces 2013 Annual Meeting Results
- J. C. Penney (JCP) Reports Successful Early Tender of 7 1/8% Notes
- SolarWinds (SWI) Acquires N-able Technologies for $120M
Create E-mail Alert Related Categories
Corporate News
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
